Tofukuji, M <br/><br/>
Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunction.  [electronic resource] 

 -  The Journal of thoracic and cardiovascular surgery  Dec 1998 
 - 1060-8 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0022-5223 
<br/><br/><label>Standard No.: </label>10.1016/S0022-5223(98)70059-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Monoclonal--therapeutic use<br/>Cardiopulmonary Bypass--adverse effects<br/>Chemotaxis, Leukocyte--drug effects<br/>Complement C5a--immunology<br/>Coronary Vessels--drug effects<br/>Endothelium, Vascular--drug effects<br/>Female<br/>Heart Arrest, Induced--adverse effects<br/>Hemodynamics--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Myocardial Reperfusion Injury--enzymology<br/>Neutrophils--drug effects<br/>Nitric Oxide Synthase--metabolism<br/>Nitric Oxide Synthase Type II<br/>Nitric Oxide Synthase Type III<br/>Peroxidase--metabolism<br/>Swine